Refine
Has Fulltext
- yes (64)
Is part of the Bibliography
- yes (64)
Year of publication
Document Type
- Journal article (51)
- Doctoral Thesis (13)
Language
- English (64) (remove)
Keywords
- active zone (10)
- optogenetics (7)
- Drosophila (5)
- synapse (5)
- cGMP (4)
- Taufliege (3)
- cAMP (3)
- neuromuscular junction (3)
- plasticity (3)
- super-resolution microscopy (3)
Institute
- Physiologisches Institut (64) (remove)
Sonstige beteiligte Institutionen
Neurogenic inflammation is evoked by neuropeptides released from primary afferent terminals and,
presumably, by other secondarily released inflammatory mediators. This study examines whether prostaglandins might participate in the development of neurogenic inflammation in humans and whether cyclooxygenase inhibitors have any anti-inflammatory effect on this type of inflammation. In healthy volunteers, neurogenic inflammation was elicited by epicutaneously applied capsaicin (1 %), after systemic pretreatment with acetylsalicylic acid, or topically applied indomethacin compared to pretreatment with saline or vehicle, respectively. The extent of neurogenic inflammation was quantified by planimetry of visible flare size and recording the increase of superficial cutaneous blood flow (SCBF) with a laser Doppler flowmeter. Capsaicin-induced flare sizes and outside SCBF (both representing neurogenically evoked inflammation) were unaffected by acetylsalicylic acid or indomethacin. Only the capsaicin-induced increase; of inside SCBF was attenuated by local pretreatment with indomethacin, reflecting the participation of prostaglandins in the inflammatory response of those areas which were in direct contact with capsaicin.
The nicotinic acetylcholine receptor of skeletal muscle is one of the best-investigated synaptic proteins and often serves as model for the entire family of pentameric ligand gated ion channels (pLGICs). Receptors of this superfamily share a common architecture. After binding the agonist the characteristic C-loop structure closes around the ligand-binding site and triggers a wave of conformational changes that spread through the protein and finally result in the opening of the channel gate. As shown before, high-resolution single channel data can hardly be described by simple kinetic mechanisms (Parzefall et al., 1998, Hallermann et al., 2005). Recent advances in the field of kinetic modelling on receptor currents demonstrate that the introduction of additional short lived shut states in kinetic schemes enhances the quality of estimates of reaction rates. The additional shut states that immediately follow ligand bound states in the mechanism are suggested to resemble the closing movement of the C-loop (Lape et al., 2008; Mukhtasimova et al., 2009). It has not been described yet whether and how the structural differences of the 2 binding sites of the receptor influence the opening behaviour. To address this question, high-resolution single channel recordings, in combination with agonists that are known to exhibit different binding site selectivity, were performed. Thereby, a detailed description of the binding site dependent generation of channel currents is possible. At the embryonic mouse-muscle receptor used in this study the ligand binding sites are located at the α-γ and α-δ subunit interfaces. By allocation of opening characteristics to the α-δ and α-γ sites it is possible to show the binding site dependent activation of distinct kinetic states. Furthermore, it will be shown that the recently introduced short-lived shut states are sufficient to describe high-resolution single channel data. Finally an enhanced kinetic mechanism based on the ‘primed states’ model, published in 2009 by Mukhtasimova et al., will be presented. In this model the structurally diverse α-δ and α-γ binding sites elicit different kinetic channel characteristics. Thus the complex high-resolution kinetic characteristics of the embryonic receptor can be described coherently.
The voltage –gated calcium channel, Cav1.2, and the plasma membrane calcium ATPase, PMCA4b, play important roles in excitable and non-excitable cells. The central function of Cav1.2 is to regulate the calcium entry into cells upon depolarization, while PMCA4b is responsible for calcium extrusion and has an influence on cellular calcium homeostasis. Both proteins control fundamental functions in the heart and brain, but the specific functions and the precise mechanisms are still investigated. In order to identify new interaction partners that may regulate the activities of the Cav1.2 and the PMCA4b, we used three independent assays and co-localization studies. The assays, which were used are PDZ domain arrays (testing 124 different PDZ domains), GST pull-downs, and conventional immunoprecipitation assays. In the PDZ arrays, strongest interactions with Cav1.2 and PMCA4b were found for the PDZ domains of MAST-205, MAGI-1, MAGI-2, MAGI-3, and ZO-1. Additionally, we established interactions between Cav1.2 and the PDZ domains of NHERF1/2, Mint-2, and CASK. PMCA4b was observed to interact with Mint-2, and its interactions with Chapsyn-110 and CASK were confirmed. Furthermore, we validated interaction of Cav1.2 and PMCA4b with NHERF1, CASK, MAST-205 and MAGI-3 via immunoprecipitation. We also demonstrated direct interaction of the C-terminus of Cav1.2 and the PDZ domain of nNOS. We assumed that nNOS overexpression would reduce Ca2+ influx through Cav1.2. To address this question, we measured Ca2+ currents in stably transfected HEK 293 cells expressing the Cav1.2 (α1b and β2a subunit of the smooth muscle L-type calcium channel) and nNOS. It has been shown that NO modulates ion channel activity by nitrosylation of sulfhydryl groups on the channel protein. So we propose that the interaction between the C-terminus of Cav1.2 and the PDZ domain of nNOS inhibits the currents by an S-nitrosylation of the channel protein. All these interactions connect both proteins to signaling networks involved in signal transmission, cell adhesion, and apoptosis, which may help provide new hints about the physiological functions of Cav1.2 and PMCA4b in intra- and intercellular signaling.
Characterisation of Mena Promoter Activity and Protein Expression in Wild-type and Gene-trapped Mice
(2011)
Proteins of the Ena/VASP protein family are important regulators of actin and participate in cell-cell and cell-matrix adhesions. To date, the physiological importance of Ena/VASP proteins for integrity of the cardiovascular system has remained unclear. To study cardiovascular functions of Mena and VASP, we used an established VASP knockout mouse in combination with a novel gene-trap-based model to ablate Mena function. In the mutated Mena mouse, the endogenous Mena gene is disrupted by the insertion of a β-galactosidase construct and β-galactosidase expression is under the control of the endogenous Mena promoter. X-gal staining of mouse organs revealed Mena promoter activity in smooth muscle layers of vessels, intestines and bronchioles, but also in cells of the brain, in cardiomyocytes and in the respiratory epithelium of bronchioles. In wild-type mice, Western blotting revealed differing protein expression patterns of VASP and Mena. Mena expression was observed in almost every tissue, predominantly in heart, lung, stomach, large intestine, testis, brain and eye. Additionally, the neuronalspecific Mena isoform was expressed in brain, eye, and slightly in heart and stomach. VASP protein, in contrast, was predominantly detected in spleen and thrombocytes. In gene-trapped mice, Mena expression was largely reduced in heart, lung and stomach but only slightly decreased in brain and testis. Immunofluorescence microscopy revealed colocalisation of Mena and F-actin at intercalated discs of cardiomyocytes and strong colocalisation of Mena and α- smooth-muscle-actin in vessels and bronchioles. Functional analysis of Mena/VASP-mutated and wild-type mice using electrocardiography suggested that the depletion of either Mena or VASP does not interfere with normal heart function. However, in double-deficient mice, the resting heart rate was significantly increased, probably reflecting a mechanism to compensate defects in ventricle contraction and to maintain a normal cardiac output. In agreement, cardiac catheter investigations suggested dilated cardiomyopathy in doubledeficient mice. Thus, although Western blot analysis showed differing protein expression patterns of Mena and VASP, these findings suggest that Mena and VASP mutually compensate for each other. Concerning Mena, we propose an important role of the protein in vessel walls, cardiomyocytes and bronchioles.
The study of animal development is one of the oldest disciplines in the field of biology and the collected data from countless investigations on numerous species have formed a general understanding of the animal life-cycle. Almost one century ago, one consequence of these intense investigations was the discovery of specific morphological changes that occur during the cleavage phase, a period that follows fertilization and egg activation at the very beginning of animal embryogenesis. These observations resulted into the formulation of the concept of a midblastula transition (MBT). So far, the mechanism of the nucleo-cytoplasmic ratio model is the only one that explains MBT regulation in a satisfying way. It suggests that the MBT is controlled by several maternal repressive factors in the egg, which are titrated out by every cell division until they lose their repressing potential. Although this regulatory mechanism was proven for several species and in different approaches, it is still only a rudimentary model for MBT control and leaves numerous questions unanswered. On this conceptual background, this thesis has shown that embryos from the medaka fish (Oryzias latipes) lose their cell cycle synchrony already after the fourth or fifth round of cell divisions, and replace it by a metasynchronous divisions pattern, in which cell division occurs in clear waves beginning in the embryo's center. The reason for this change in division mode is still unknown, although several hypotheses were put forward, most notable a difference in yolk-access between cells. However, this theory was weakened by division waves that progressed from one embryonic pole to the opposing one, which were occasionally observed in deformed embryos, leaving the mechanism for this phenomenon furthermore unclear. Those deformed embryos were most likely the result of asymmetric cell divisions at very early stages, a phenomenon which occurred in a significant percentage of medaka embryos and which directly influenced the equal distribution of cytoplasmic material. It could not beuncovered what kind of effects this unequal distribution of cytoplasm exerted on the progression of embryonic development, but it can be argued that relevant differences in cell volumes could result in cell clusters that will enter MBT at different time points. Comparable observations were already made in other species and it was hypothesized that they were the direct results of early unequal cell cleavages. Finally, it was demonstrated that zygotic transcription in medaka embryos is activated prior to the hitherto assumed time of the first transcriptional initiation. Moreover, indications were found that strongly speak for a transcriptional activation that occurs in two steps; a first step at the 16-cell stage when first cells were identified positive for RNAPII phosphorylation, and a second step at the 64-cell stage, when the number of p-RNAPII positive cells significantly increased. A stepwise activation of zygotic transcription was already observed in other species, but only for the overall increasing amount of mRNAs and irrespective of the actual number of transcriptionally active cells within the embryos. .. Overall, these data confirm and expand the basic knowledge of pre-MBT embryos and about the MBT itself. Furthermore, they also suggest that many early processes in pre-MBT embryos are only rudimentarily understood or still totally unknown.
Recent studies show that combinations of defined key developmental transcription factors (TFs) can reprogram somatic cells to pluripotency or induce cell conversion of one somatic cell type to another. However, it is not clear if single genes can define a cells identity and if the cell fate defining potential of TFs is also operative in pluripotent stem cells in vitro. Here, we show that ectopic expression of the neural TF Neurogenin2 (Ngn2) is sufficient to induce rapid and efficient differentiation of embryonic stem cells (ESCs) into mature glutamatergic neurons. Ngn2-induced neuronal differentiation did not require any additional external or internal factors and occurred even under pluripotency-promoting conditions. Differentiated cells displayed neuron-specific morphology, protein expression, and functional features, most importantly the generation of action potentials and contacts with hippocampal neurons. Gene expression analyses revealed that Ngn2-induced in vitro differentiation partially resembled neurogenesis in vivo, as it included specific activation of Ngn2 target genes and interaction partners. These findings demonstrate that a single gene is sufficient to determine cell fate decisions of uncommitted stem cells thus giving insights into the role of key developmental genes during lineage commitment. Furthermore, we present a promising tool to improve directed differentiation strategies for applications in both stem cell research and regenerative medicine.
Aims: Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Elevation of myocyte cyclic GMP levels by local actions of endogenous atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) or by pharmacological inhibition of phosphodiesterase-5 was shown to counter-regulate pathological hypertrophy. It was suggested that cGMP-dependent protein kinase I (cGKI) mediates this protective effect, although the role in vivo is under debate. Here, we investigated whether cGKI modulates myocyte growth and/or function in the intact organism.
Methods and results: To circumvent the systemic phenotype associated with germline ablation of cGKI, we inactivated the murine cGKI gene selectively in cardiomyocytes by Cre/loxP-mediated recombination. Mice with cardiomyocyte-restricted cGKI deletion exhibited unaltered cardiac morphology and function under resting conditions. Also, cardiac hypertrophic and contractile responses to β-adrenoreceptor stimulation by isoprenaline (at 40 mg/kg/day during 1 week) were unaltered. However, angiotensin II (Ang II, at 1000 ng/kg/min for 2 weeks) or transverse aortic constriction (for 3 weeks) provoked dilated cardiomyopathy with marked deterioration of cardiac function. This was accompanied by diminished expression of the \([Ca^{2+}]_i\)-regulating proteins SERCA2a and phospholamban (PLB) and a reduction in PLB phosphorylation at Ser16, the specific target site for cGKI, resulting in altered myocyte \(Ca^{2+}_i\) homeostasis. In isolated adult myocytes, CNP, but not ANP, stimulated PLB phosphorylation, \(Ca^{2+}_i\)-handling, and contractility via cGKI.
Conclusion: These results indicate that the loss of cGKI in cardiac myocytes compromises the hypertrophic program to pathological stimulation, rendering the heart more susceptible to dysfunction. In particular, cGKI mediates stimulatory effects of CNP on myocyte \(Ca^{2+}_i\) handling and contractility.
PDZ (PSD-95/Disc large/Zonula occludens-1) protein interaction domains bind to cytoplasmic protein C-termini of transmembrane proteins. In order to identify new interaction partners of the voltage-gated L-type \(Ca^{2+}\) channel Cav1.2 and the plasma membrane \(Ca^{2+}\) ATPase 4b (PMCA4b), we used PDZ domain arrays probing for 124 PDZ domains. We confirmed this byGST pulldowns and immunoprecipitations. In PDZ arrays, strongest interactionswith \(Ca_v1.2\) and PMCA4b were found for the PDZ domains of SAP-102, MAST-205, MAGI-1, MAGI-2, MAGI-3, and ZO-1. We observed binding of the \(Ca_v1.2\) C-terminus to PDZ domains of NHERF1/2, Mint-2, and CASK. PMCA4b was observed to interact with Mint-2 and its known interactions with Chapsyn-110 and CASK were confirmed. Furthermore, we validated interaction of \(Ca_v1.2\) and PMCA4b with NHERF1/2, CASK,MAST-205 and MAGI-3 viaimmunoprecipitation. We also verified the interaction of \(Ca_v1.2\) and nNOS and hypothesized that nNOS overexpression might reduce \(Ca^{2+}\) influx through \(Ca_v1.2\). To address this, we measured \(Ca^{2+}\) currents in HEK 293 cells co-expressing \(Ca_v1.2\) and nNOS and observed reduced voltage-dependent \(Ca_v1.2\) activation. Taken together, we conclude that \(Ca_v1.2\) and PMCA4b bind promiscuously to various PDZ domains, and that our data provides the basis for further investigation of the physiological consequences of these interactions.
Synaptic plasticity shapes the development of functional neural circuits and provides a basis for cellular models of learning and memory. Hebbian plasticity describes an activity-dependent change in synaptic strength that is input-specific and depends on correlated pre- and postsynaptic activity. Although it is recognized that synaptic activity and synapse development are intimately linked, our mechanistic understanding of the coupling is far from complete. Using Channelrhodopsin-2 to evoke activity in vivo, we investigated synaptic plasticity at the glutamatergic Drosophila neuromuscular junction. Remarkably, correlated pre- and postsynaptic stimulation increased postsynaptic sensitivity by promoting synapse-
specific recruitment of GluR-IIA-type glutamate receptor subunits into postsynaptic receptor fields. Conversely, GluR-IIA was rapidly removed from synapses whose activity failed to evoke substantial postsynaptic depolarization. Uniting these results with developmental GluR-IIA dynamics provides a comprehensive physiological concept of how Hebbian plasticity guides synaptic maturation and sparse transmitter release controls the stabilization of the molecular composition of individual synapses.